Business

CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting

CareDx Hosting Pan-Organ Symposium, "Elevating Transplant Care by Combining Molecular Diagnostics and Artificial Intelligence" BRISBANE, Calif.--(BUSINESS

articleCaredx, Inc.February 22, 20233/company/caredx-inc/news/caredx-showcases-clinical-value-of-multimodality-and-ai-innovation-at-the-american
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting

About this update from Caredx, Inc.

[{"type":"text","content":"\nCareDx Hosting Pan-Organ Symposium, \"Elevating Transplant Care by Combining Molecular Diagnostics and Artificial Intelligence\"\n\n BRISBANE, Calif.--(BUSINESS WIRE)--\nCareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers -- today announced that it is showcasing the clinical value of multimodality and artificial intelligence innovation at the annual American Society of Transplantation Cutting Edge of Transplantation (CEoT) meeting taking place February 23-25, in Scottsdale, Arizona.\n\n\"We are excited to be part of this year's CEoT meeting which brings together world-class leaders who are collectively challenging the status quo by driving innovation and new frontiers in transplantation,\" said Reg Seeto, CEO and President of CareDx. \"I am extremely proud of the progress CareDx has made in bolstering these efforts by providing innovative, multimodal and artificial intelligence-enabled solutions that are poised to make a seminal difference in improving patients' long-term allograft health.\"\n\nCareDx has assembled leading experts who will discuss the latest scientific advancements in kidney, heart, and lung transplantation. The symposium, \"Elevating Transplant Care by Combining Molecular Diagnostics and Artificial Intelligence,\" will be held on Friday, February 24, from 7:00 am – 8:15 am. Speakers include:\n\nAbdominal\n\n\nSanjiv Anand, MD, MS, Medical Director, Living Donor Kidney Program, Intermountain Medical Center\n\n\nEnver Akalin, MD, FAST, FASN, Medical Director, Kidney and Pancreas Transplantation, Montefiore Medical Center; Director, Transplant Nephrology Fellowship, Professor of Medicine, Albert Einstein College of Medicine\n\n\nTitte \"Srini\" Srinivas, MD, MBA, FAST, Senior Vice President, Medical Affairs and Clinical Operations, CareDx\n\n\nNikhil Agrawal, MD, Senior Medical Director, CareDx\n\n\nCardiothoracic\n\n\nSean Pinney, MD, Professor of Medicine; Co-Director, Heart and Vascular Center; Director, Richard P. Parrillo Family Center for Clinical and Translational Cardiology; Director, Advanced Heart Failure, Transplant and Mechanical Circulatory Support, University of Chicago Medicine\n\n\nHoward Huang, MD, Transplant Pulmonologist...

More updates from Caredx, Inc.